-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 9, Zuoli Pharmaceuticals issued an announcement stating that the company received the "Drug Registration Certificate" for polycarbophil calcium tablets approved and issued by the National Medical Products Administration for the relief of patients with irritable bowel syndrome (constipation).
The polycarbophil calcium tablets of Zuoli Pharmaceuticals are researched and developed using Polyful® from Mylan Company of Japan as the reference drug.
Polycarbophil calcium, the active ingredient in polycarbophil calcium tablets, has very unique biochemical properties.
Polycarbophil calcium itself is an inert, non-absorbable high molecular polymer.
In addition, polycarbophil calcium tablets and Wuling capsules have a certain synergistic effect in the application of gastroenterology